Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
NCT03295981 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-04-22
Summary
The purpose of the clinical study is to investigate whether the local delivery of bisphosphonate as a surgical adjuvant can decrease the chance of a giant cell tumor of bone coming back to the same location. The hypothesis is that the local administration of bisphosphonate will decrease the rate of the tumor returning compared to traditional aggressive surgical removal of the tumor.
Conditions
- Giant Cell Tumor of Bone
Interventions
- DRUG
-
Zoledronic Acid
4 mg of zoledronic acid (Zometa) will be added to each bag of bone cement
Sponsors & Collaborators
-
Orthopedic Research and Education Foundation
collaborator OTHER -
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
collaborator OTHER -
University of Iowa
collaborator OTHER - collaborator OTHER
-
McGill University Health Centre/Research Institute of the McGill University Health Centre
collaborator OTHER -
The Cleveland Clinic
collaborator OTHER -
Wake Forest University
collaborator OTHER -
University of Kansas
collaborator OTHER -
Indiana University
collaborator OTHER -
University of Oklahoma
collaborator OTHER -
Beth Israel Deaconess Medical Center
collaborator OTHER - collaborator OTHER
-
American Academy of Orthopaedic Surgeons
collaborator OTHER -
Massachusetts General Hospital
collaborator OTHER -
All India Institute of Medical Sciences
collaborator OTHER - collaborator OTHER
-
University of California
collaborator OTHER -
St. Louis University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-05-03
- Primary Completion
- 2027-01-31
- Completion
- 2028-01-31
- FDA Drug
- Yes
Countries
- United States
- Canada
- India
Study Locations
More Related Trials
-
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
NCT00742924 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions
NCT00375427 ·Status: COMPLETED ·Phase: PHASE3
-
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
NCT00003884 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation
NCT00264420 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
NCT00172003 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer
NCT00002931 ·Status: COMPLETED ·Phase: PHASE2
-
BGJ398 for the Treatment of Tumor-Induced Osteomalacia
NCT03510455 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions
NCT00029224 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
NCT00321464 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain
NCT03523351 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma
NCT00002982 ·Status: COMPLETED ·Phase: PHASE2
-
ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases
NCT00294437 ·Status: TERMINATED ·Phase: PHASE3
-
Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid
NCT02069340 ·Status: WITHDRAWN ·Phase: NA
-
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
NCT00003406 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
NCT00792948 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
NCT02306161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone
NCT00458796 ·Status: TERMINATED ·Phase: NA
-
Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00002481 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
NCT00003101 ·Status: COMPLETED ·Phase: PHASE2
-
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
NCT00869206 ·Status: COMPLETED ·Phase: PHASE3
-
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
NCT00365105 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT00002522 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
NCT00558272 ·Status: COMPLETED ·Phase: PHASE2
-
Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma
NCT00028665 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma
NCT00004907 ·Status: COMPLETED ·Phase: PHASE1/PHASE2